Study of repeat atrial fibrillation risk after ablation
Part of Heart & circulation clinical trials.
This study follows adults who have had a procedure to treat an irregular heartbeat, to understand who is more likely to have it return. It may help doctors predict risk and plan follow-up after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You have been diagnosed with atrial fibrillation based on an ECG or a Holter heart monitor test.
- You do not have a blood cancer, autoimmune disease, or any cancer.
- You can move and care for yourself; you are not unable to move due to stroke-related paralysis or severe injuries.
- You are expected to live at least 2 years.
- You are able to participate in follow-up visits and are likely to stay in contact with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.
This trial is looking at what happens after a heart procedure called catheter ablation for atrial fibrillation (an irregular heartbeat). It mainly collects follow-up outcomes to better understand recovery and results for patients.
This study looks at patients who have both atrial fibrillation (irregular heartbeats) and heart failure. It aims to predict health outcomes for people who are having a procedure called ablation, which aims to restore a normal heart rhythm. Participating could help doctors understand who might benefit most from this treatment.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.